Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | ATM | Q13315 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.38 |
| ▸ | RXRA | P19793 | 1/20 | 0.35 |
| ▸ | RXRB | P28702 | 1/20 | 0.35 |
| ▸ | PDK2 | Q15119 | 7/20 | 0.32 |
| ▸ | AKR1C4 | P17516 | 1/20 | 0.31 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.31 |
| ▸ | AKR1C2 | P52895 | 1/20 | 0.31 |
| ▸ | AKR1C1 | Q04828 | 1/20 | 0.31 |
| ▸ | TSPO | P30536 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12306526 | 0.94 | KDM4E (0.46) | KDM4EATML3MBTL1HDAC4RXRA | |
| SCHEMBL17562299 | 0.94 | KDM4E (0.36) | KDM4EATML3MBTL1HDAC4RXRA | |
| SCHEMBL20232324 | 0.92 | KDM4E (0.41) | KDM4EATML3MBTL1HDAC4RXRA | |
| SCHEMBL12306587 | 0.92 | L3MBTL1 (0.47) | KDM4EATML3MBTL1HDAC4RXRA | |
| SCHEMBL12414494 | 0.92 | KDM4E (0.43) | KDM4EATML3MBTL1HDAC4RXRA | |
| SCHEMBL24694039 | 0.91 | KDM4E (0.34) | KDM4EATML3MBTL1HDAC4RXRA | |
| SCHEMBL17562344 | 0.91 | KDM4E (0.34) | KDM4EATML3MBTL1HDAC4RXRA | |
| SCHEMBL18778031 | 0.91 | KDM4E (0.34) | KDM4EATML3MBTL1HDAC4RXRA | |
| SCHEMBL18778026 | 0.91 | KDM4E (0.34) | KDM4EATML3MBTL1HDAC4RXRA | |
| SCHEMBL13382211 | 0.90 | KDM4E (0.42) | KDM4EATML3MBTL1HDAC4RXRA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170117487-A1 | Heterocyclic Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2017-04-27 | — | — | US | disclosed |
| US-20170117487-A1 | Heterocyclic Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2017-04-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170117487-A1 | Heterocyclic Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device | RECQL, HSF1, DDX41 | KDM4E 2319/4885ATM 1948/4885L3MBTL1 1123/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.